[Combined therapy for the chronic pelvic pain syndrome]
- PMID: 15267206
[Combined therapy for the chronic pelvic pain syndrome]
Abstract
Objective: To study the clinical diagnosis and treatment of the chronic pelvic pain syndrome (CPPS).
Methods: According to National Institute Health (NIH) classification, 165 cases of chronic prostatitis were surveyed by analysis of their laboratory results and clinical history. In addition, the chronic prostatitis symptom index (CPSI) of each patient was evaluated. All patients were treated for 6 to 8 weeks, type III A with antibiotics and alpha1 receptor inhibitor, type III B with alpha1 receptor inhibitor, diazepam diclogenatis and other narcotics. All cases were additionally treated by psychological and physical therapies. Traditional Chinese Medicine was also used in some cases.
Results: Based on the results of CPSI after 6 weeks treatment, 121 (73.3%) significantly improved, 26 (15.8%) slightly improved and only 18(10.9%) did not respond to the therapy.
Conclusion: Combined therapy can be an effective treatment for the chronic pelvic pain syndrome.
Similar articles
-
[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].Zhonghua Nan Ke Xue. 2009 Aug;15(8):717-20. Zhonghua Nan Ke Xue. 2009. PMID: 19852273 Clinical Trial. Chinese.
-
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.Urology. 2010 Jun;75(6):1249-53. doi: 10.1016/j.urology.2010.01.021. Epub 2010 Apr 3. Urology. 2010. PMID: 20363491
-
[Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].Hinyokika Kiyo. 2010 Apr;56(4):215-9. Hinyokika Kiyo. 2010. PMID: 20448445 Japanese.
-
Role of alpha1-blockers in chronic prostatitis syndromes.BJU Int. 2008 Mar;101 Suppl 3:11-6. doi: 10.1111/j.1464-410X.2008.07496.x. BJU Int. 2008. PMID: 18307680 Review.
-
Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.Expert Opin Pharmacother. 2010 Jun;11(8):1255-61. doi: 10.1517/14656561003709748. Expert Opin Pharmacother. 2010. PMID: 20429665 Review.
Cited by
-
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2019 Oct 6;10(10):CD012552. doi: 10.1002/14651858.CD012552.pub2. Cochrane Database Syst Rev. 2019. PMID: 31587256 Free PMC article. Review.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 May 12;5(5):CD012551. doi: 10.1002/14651858.CD012551.pub3. Cochrane Database Syst Rev. 2018. PMID: 29757454 Free PMC article. Review.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 Jan 26;1(1):CD012551. doi: 10.1002/14651858.CD012551.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 May 12;5:CD012551. doi: 10.1002/14651858.CD012551.pub3. PMID: 29372565 Free PMC article. Updated. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical